Live News Categoriesequity

BAL (BAL) News

Follow BAL (BAL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol BAL Asset equity Sector Markets 90 days 0 Last 61.92 Updated Jul 06, 2026, 11:30 AM UTC Open live news feed Open BAL chart & news

L Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active L Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 2026 EQUITY | Jul 06, 2026, 11:30 AM UTC